Alexa E, Sumalan RM, Danciu C, Obistioiu D, Negrea M, Poiana MA, Rus C, Radulov I, Pop G, Dehelean C (2018) Synergistic antifungal, allelopatic and anti-proliferative potential of
Salvia officinalis L., and Thymus vulgaris L. essential oils. Molecules 23: 185.
Baj T, Biernasiuk A, Wróbel R, Malm A (2020) Chemical composition and in vitro activity of Origanum vulgare L., Satureja hortensis L., Thymus serpyllum L. and Thymus vulgaris L. essential oils towards oral isolates of
Candida albicans and
Candida glabrata. Open Chem 18: 108-118.
Bolatchiev A, Baturin V, Bazikov I, Maltsev A, Kunitsina E (2020) Effect of antimicrobial peptides HNP-1 and hBD-1 on
Staphylococcus aureus strains in vitro and in vivo. Fundam Clin Pharmacol 34: 102-108.
Bona E, Cantamessa S, Pavan M, Novello G, Massa N, Rocchetti A, Berta G, Gamalero E (2016) Sensitivity of Candida albicans to essential oils: are they an alter native to antifungal agents? J Appl Microbiol 121: 1530-1545.
Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC (2010) In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin Exp Dermatol 35: 658-663.
Cavalcanti YW, Almeida LF, Padilha WW (2011) Anti adherent activity of Rosmarinus officinalis essential oil on Candida albicans: an SEM analysis. Rev Odonto Ciênc 26: 139-144.
CDC (2019) Fungal Diseases.
https://www.cdc.gov/fungal//diseases/candidiasis/index.html CLSI, Clinical and Laboratory Standards Institute (2008) M27-A3: Reference Method for Broth Dilution Anti fungal Susceptibility Testing of Yeasts. 3rd ed. USA: Wayne, PA.
de Oliveira Santos GC, Vasconcelos CC, Lopes AJ, de Sousa Cartágenes M, Filho AK, do Nascimento FR, Ramos RM, Pires ER, de An-drade MS, Rocha FM, de Andrade Monteiro C (2018) Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents. Front Microbiol 9: 1351.
Dignani MC, Solomkin JS, Anaissie EJ (2009) Candida. In: Anaissie EJ, McGinnis MR, Pfaller MA (eds) Clinical mycology. Churchill Livingstone, London, pp 197-229.
Duarte MC, Figueira GM, Sartoratto A, Rehder VL, Delarmelina C (2005) Anti-Candida activity of Brazilian medicinal plants. J Ethnopharmacol 97: 305-311.
Elansary HO, Abdelgaleil SA, Mahmoud EA, Yessoufou K, Elhindi K, El-Hendawy S (2018) Effective antioxidant, antimicrobial and anti-cancer activities of essential oils of horticultural aromatic crops in northern Egypt. BMC Complement Altern Med 18: 214.
Fani M, Kohanteb J (2017) In vitro antimicrobial activity of Thymus vulgaris essential oil against major oral pathogens. J Evid Based Complementary Altern Med 22: 660-666.
Hristova Y, Wanner J, Jirovetz L, Stappen I, Iliev I, Gochev V (2015) Chemical composition and antifungal activity of essential oil of
Hyssopus officinalis L. from Bulgaria against clinical isolates of Candida species. Biotechnol Biotechnol Equip 29: 592-601.
Karpiński TM (2020) Essential oils of Lamiaceae family plants as antifungals. Biomolecules 10: 103.
Martins N, Ferreira IC, Barros L, Silva S, Henriques M (2014) Candidiasis: predisposing factors, prevention, diagnosis and alternative treat-ment. Mycopathologia 177: 223-240.
Nelson M, Wanjiru W, Margaret M (2013) Identification and susceptibility profile of vaginal Candida species to antifungal agents among pregnant women attending the antenatal clinic of Thika District Hospital, Kenya. Open J Med Microbiol 3: 239-247.
Nuzhat T, Vidyasagar GM (2014) Antifungal investigations on plant essential oils. A review. Int J Pharm Pharm Sci 5 (Suppl 2): 19-28.
Oksuz S, Sahin I, Yildirim M, Gulcan A, Yavuz T, Kaya D, Koc AN (2007) Phospholipase and proteinase activities in different Candida species isolated from anatomi cally distinct sites of healthy adults. Jpn J Infect Dis 60: 280-283.
Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voricona-zole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48: 1366-1377.
Pristov KE, Ghannoum MA (2019) Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect 25: 792-798.
Příborský J (2018) Antimykotika. In: Švihovec J, Bultas J, Anzenbacher P, Chládek J, Příborský J, Slíva J, Votava M (eds) Farmakologie. Grada, Česká Republika, pp 773-782.
Raut JS, Karuppayil SM (2014) A status review on the medi cinal properties of essential oils. Ind Crops Prod 62: 250-264.
Scalas D, Mandras N, Roana J, Tardugno R, Cuffini AM, Ghisetti V, Benvenuti S, Tullio V (2018) Use of
Pinus sylvestris L.(Pinaceae),
Origanum vulgare L.(Lamiaceae), and
Thymus vulgaris L.(Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains. BMC Complement Altern Med 18: 143.
Sookto T, Srithavaj T, Thaweboon S, Thaweboon B, Shrestha B (2013) In vitro effects of Salvia officinalis L. essential oil on Candida albicans. Asian Pac J Trop Biomed 3: 376-380.
Vlase L, Benedec D, Hanganu D, Damian G, Csillag I, Sevastre B, Mot AC, Silaghi-Dumitrescu R, Tilea I (2014) Evaluation of antioxidant and antimicrobial activities and phenolic profile for Hyssopus officinalis, Ocimum basilicum and Teucrium chamaedrys. Molecules 19: 5490-5507.
Wall G, Lopez-Ribot JL (2020) Current antimycotics, new prospects, and future approaches to antifungal therapy. Antibiotics (Basel) 9: 445.
en
pl
